Ticagrelor CAS No.: 274693-27-5

We are a manufacturer based in China. We specialize in providing high-quality Ticagrelor CAS No.: 274693-27-5 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.

Category:Pharmaceutical Materials   Own Brand:MT  /MOQ:100KG  /From China/  B2B only.

Tags:

Advantage:Customizable,Please tell me your specific needs↓↓↓

Introduction

Ticagrelor, marketed under brand names such as Brilinta® and Brilique®, is an oral, reversible P2Y12 adenosine diphosphate (ADP) receptor antagonist used to reduce thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or those undergoing percutaneous coronary intervention (PCI). Its CAS number is 274693-27-5, with a molecular formula of C₂₃H₂₈F₂N₆O₄S and a molecular weight of 522.57 g/mol. Ticagrelor inhibits platelet aggregation by blocking the P2Y12 receptor, offering a faster onset of action compared to clopidogrel. Approved by the FDA in 2011, it has demonstrated superiority in reducing cardiovascular mortality and stent thrombosis in clinical trials like PLATO. Safety considerations include a risk of bleeding, dyspnea, and potential interactions with CYP3A4 inhibitors or inducers.

Usage: Used as an anticoagulant to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS).

Packaging and Shipping: 25KG/drum or as per buyer requirement.

Storage: Stored in a cool, ventilated warehouse, should be separated from oxidizer, edible chemicals, do not mix storage. Keep container closed and away from fire and heat.

Name Ticagrelor (Brilinta/Brilique)
CAS No. 274693-27-5
Molecular Formula C₂₃H₂₈F₂N₆O₄S
Molecular Weight 522.57 g/mol
Appearance White solid
Indications Acute coronary syndrome (ACS), unstable angina, myocardial infarction (MI)
Mechanism Reversible P2Y12 receptor antagonist; inhibits platelet aggregation
Pharmacokinetics Rapid absorption (Tmax=2-3h), high plasma protein binding (>99.8%), metabolized via CYP3A4/3A5, half-life=6.7-9.1h
Adverse Effects Dyspnea, bleeding (nose/subcutaneous), rare allergic reactions, hepatotoxicity
Storage Sealed, cool (room temperature), dry conditions
Packaging 10mg, 25mg, 50mg (customizable)

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.

Inquiry

                               

    Factory & Shipment

    chemical factory
    chemical factory
    Powder Coatings
    chemical factory